SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14C - Other definitive information statements:
SEC Accession No. 0001683168-24-001487
Filing Date
2024-03-15
Accepted
2024-03-15 11:14:06
Documents
1
Period of Report
2024-03-20

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE INFORMATION STATEMENT sunshine_def14c.htm DEF 14C 73923
  Complete submission text file 0001683168-24-001487.txt   75239
Mailing Address 1177 AVENUE OF THE AMERICAS 5TH FLOOR NEW YORK NY 10036
Business Address 1177 AVENUE OF THE AMERICAS 5TH FLOOR NEW YORK NY 10036 332-216-1147
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

IRS No.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: DEF 14C | Act: 34 | File No.: 001-41282 | Film No.: 24753104
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)